Phenomenex India looks forward to strong customer service

Phenomenex India has promoted technical seminars throughout the country along with on-site demonstrations, where it has trained scientists who stand alongside the customers during their challenging method-development activities.


Mr Nicholas (Nick) Mitchell, Managing Director, Phenomenex India Private Limited

In its third year of business in India, Phenomenex India is continuing to expand on its original position for moving directly into the Indian market, namely unparalleled customer service and support. To that end, Phenomenex has strived to hire the astute and technically trained
application specialists in the industry.

In an interview to Raj Gunashekar, Nicholas (Nick) Mitchell, Managing Director, Phenomenex India Private Ltd, Hyderabad, outlines the plans of the company and market opportunities.

What are the current market trends for separation science industries in India?

The current market trends in India's separation science market are incredibly competitive. With the recent significant decline in the rupee (and a two year trend of the same since 2011), all of the major import suppliers are facing similar issues with regard to ever-eroding margins. Although quick advances in market share might seem appealing to some of the smaller players, it is the responsibility of the MNC Life Science suppliers, domestic distributors, and our good customers in India to help maintain a strong value for our high technology products and resources we employ to support them. Our customers in the Indian market must continue to recognize that in order to provide the newest advances in separation science to the Indian market; customers must be willing to make the investment for these solutions to their most challenging separations.

The alternative can lead to disastrous consequences for the export-oriented Indian firms capturing global market share. If the quality of these products comes into question because of the lack of validation of proper testing platforms provided by internationally recognized MNC's in the Life Science market, a key segment of the Indian export economy could be at risk.


Previous 1 3 4 5 6 7 Next
1 Comment Comment 1 - 1 of 1

Dr. T. Shantibala 5 August 2014 at 03:26 PM

want to enquire about HPLC column


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email